12th Jan 2026 06:00
Reference is made to the convertible bond agreement with CVI Investments, Inc. dated 22 December 2023 (as amended 16 May 2025).
On 9 January 2026, IDEX Biometrics ASA received a Conversion Notice from CVI Investments, Inc. to convert 15 bonds with a total value of NOK 4,998,000 at a conversion price of NOK 6.50 per share.
Following the conversion, the Company's share capital increases by NOK 768,923 from NOK 62,600,677 to NOK 63,369,600 through the issuance of 768,923 new shares to CVI Investments, Inc. The Company's share capital is now NOK 63,369,600 divided into 63,369,600 shares, each with a nominal value of NOK 1.00.
ContactsAnders Storbråten, CEO and CFO, Tel: +47 416 38 582E-mail: [email protected]
About UsIDEX Biometrics ASA (OSE: IDEX) is shaping the future of access and payments.
IDEX Biometrics is advancing the future of access and payments with identity-first biometrics. With over a decade of proprietary innovation, our solutions are proven in the field, globally certified, and trusted by leading financial institutions. We serve enterprises, the public sector, banks, and issuers directly and through partners, delivering secure, seamless experiences in digital and physical access and payments. For more information, visit www.idexbiometrics.com
This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-01-12 07:00 CET.
AttachmentsIDEX Biometrics ASA: Conversion of bonds and share capital increase
Related Shares:
Idex Bio Ord